PRF Technologies (PRFX) Long-Term Investments (2022 - 2025)

PRF Technologies (PRFX) posted quarterly Long-Term Investments of $7.6 million for Q4 2025, up 7783.51% year-on-year from $97000.0 in Q4 2024, and up 5.43% on a QoQ basis from $7.3 million in Q2 2025.

PRF Technologies (PRFX) Long-Term Investments (2022 - 2025) Analysis & Trends

PRF Technologies (PRFX) has reported Long-Term Investments for 4 consecutive years, with $7.6 million the latest figure, recorded in Q4 2025.

  • Quarterly Long-Term Investments rose 7783.51% year-over-year to $7.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.6 million (up 7783.51% YoY) and the FY2025 annual result came in at $7.6 million, up 7783.51% from the prior year.
  • Long-Term Investments improved to $7.6 million in Q4 2025 per PRFX's latest filing, from $7.3 million in the prior quarter.
  • Over the last five years, Long-Term Investments for PRFX reached as high as $7.6 million in Q4 2025 and fell as low as $44000.0 in Q4 2022.
  • A 4-year average of $2.5 million and a median of $123000.0 in 2023 frame the typical range for Long-Term Investments.
  • Annual changes were most pronounced in 2024 — Long-Term Investments declined 25.95% — and 2025, when it soared 7783.51%.
  • Year by year, Long-Term Investments stood at $44000.0 in 2022, then surged by 197.73% to $131000.0 in 2023, then dropped by 25.95% to $97000.0 in 2024, then surged by 7783.51% to $7.6 million in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods registered $7.6 million, $7.3 million, and $97000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 56.09 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 1.32 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 702.35 Mn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 146.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 PRF Technologies 745,168.93 451,168.93 - 7.65 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 7.65 Mn
Jun 30, 2025 7.25 Mn
Dec 31, 2024 97,000.00
Jun 30, 2024 115,000.00
Dec 31, 2023 131,000.00
Dec 31, 2022 44,000.00